These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 880980)

  • 21. Remodelling of the heart in DOCA-salt hypertensive rats by propranolol and by an alpha-2 agonist, rilmenidine.
    Callens-el Amrani F; Paolaggi F; Swynghedauw B
    J Hypertens; 1989 Dec; 7(12):947-54. PubMed ID: 2576430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sustained pressore responsiveness to prolonged hypothalamic stimulation in awake rats.
    Buñag RD; Riley E; Montello M
    Am J Physiol; 1976 Dec; 231(6):1708-15. PubMed ID: 990109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of propranolol in chronic two-kidney Goldblatt hypertension in rats.
    Gulati OP; Liard JF
    Arch Int Pharmacodyn Ther; 1979 Aug; 240(2):285-93. PubMed ID: 508010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Propranolol in conscious spontaneously hypertensive rats. I. Cardiovascular effects after subcutaneous and intracerebroventricular administration.
    Smits JF; van Essen H; Struyker-Boudier HA
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Oct; 309(1):13-8. PubMed ID: 522893
    [No Abstract]   [Full Text] [Related]  

  • 25. Chlorthalidone-modulated vascular responses to vasodilator stimuli in DOCA-salt hypertensive rats.
    Bissoli NS; Vasquez EC; Cabral AM
    Pharmacol Res; 1996 Jan; 33(1):47-54. PubMed ID: 8817646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of endothelin-3 on blood pressure in conscious spontaneously hypertensive [SHR] and DOCA-salt hypertensive rats.
    Januszewicz A; Loń S; Lapiński M; Styś A
    J Physiol Pharmacol; 1994 Mar; 45(1):105-19. PubMed ID: 8043901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alterations in blood pressure of normotensive and hypertensive rats following intrathecal injections of neuropeptide Y.
    Chen X; Henderson K; Beinfeld MC; Westfall TC
    J Cardiovasc Pharmacol; 1988 Oct; 12(4):473-8. PubMed ID: 2465449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Left ventricular compliance in the DOCA-salt model of hypertension in the rat. Effects of propranolol.
    Cheav SL; Delcayre C; Besnard JC; Paolaggi F; Mouas C; Swynghedauw B
    Arch Int Pharmacodyn Ther; 1991; 314():5-24. PubMed ID: 1840461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of D- and DL-propranolol on blood pressure and cerebral norepinephrine in rats with DOCA-hypertension.
    Lydtin H; Sommerfeldt H
    Int J Clin Pharmacol; 1972 Nov; 6(4):328-31. PubMed ID: 4641848
    [No Abstract]   [Full Text] [Related]  

  • 30. Cardiovascular effects of intracerebroventricular injection of vasopressin in unanaesthetized normotensive and DOCA-salt hypertensive rats.
    Berecek KH; Mah SC; Baum P; Hofbauer KG
    J Hypertens Suppl; 1984 Dec; 2(3):S29-31. PubMed ID: 6599674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypotensive action of OPC-1427, a new beta-adrenergic blocking agent in rats.
    Sugawara K; Takami N; Ozaki M
    Arch Int Pharmacodyn Ther; 1979 Aug; 240(2):294-304. PubMed ID: 41497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pressor effect of beta-adrenergic receptor blocking drugs in spontaneously hypertensive rats treated with clonidine.
    Sloos R; van Zwieten PA
    J Cardiovasc Pharmacol; 1979; 1(4):441-8. PubMed ID: 94621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of intraventricular and intraspinal 6-hydroxydopamine on blood pressure of DOCA-saline hypertensive rats.
    Kubo T; Hashimoto M
    Arch Int Pharmacodyn Ther; 1979 Mar; 238(1):50-9. PubMed ID: 485704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. KCl inhibits hypothalamic activity to attenuate hypertension in DOCA-salt rats.
    Sasaki S; Takeda K; Takahashi H; Yoneda S; Okajima H; Iyoda I; Yoshimura M; Ijichi H
    Jpn Circ J; 1984 Nov; 48(11):1251-9. PubMed ID: 6502916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blunted pressor responsiveness to quinpirole, a specific dopamine D2 receptor agonist, in conscious deoxycorticosterone acetate/NaCl hypertensive rats is related to atrial natriuretic peptide release.
    Chen YF; Jin HK; Paul R; Nagahama S
    J Pharmacol Exp Ther; 1988 Aug; 246(2):485-92. PubMed ID: 2969976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats.
    Schiffrin EL; Turgeon A; Deng LY
    Br J Pharmacol; 1997 Jul; 121(5):935-40. PubMed ID: 9222550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Greater calmodulin-dependent regulation of neurotransmitter release and vascular responsiveness in chronic Doca-salt hypertension.
    Tsuda K; Tsuda S; Goldstein M; Masuyama Y
    Am J Hypertens; 1989 Feb; 2(2 Pt 1):93-8. PubMed ID: 2537092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sympathetic and pressor hyperresponsiveness to intracisternal injections of hypertonic NaCl in DOCA hypertensive rats.
    Takeda K; Sasaki S; Ashizawa H; Shikuma R; Takahashi H; Yoshimura M; Nakagawa M; Ijichi H
    Jpn Circ J; 1981 Sep; 45(9):1126-9. PubMed ID: 7300022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of propranolol on development and maintanance of severe renal hypertension in rats.
    Leenen FH; Ackerman EW
    Clin Exp Pharmacol Physiol; 1976; 3(6):575-86. PubMed ID: 1009694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of vasopressin V1- and V2-receptor stimulation on blood pressure in DOCA-salt hypertensive rats.
    Mimura Y; Ogura T; Yamauchi T; Otsuka F; Oishi T; Harada K; Hashimoto M; Ota Z
    Acta Med Okayama; 1995 Aug; 49(4):187-94. PubMed ID: 7502678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.